Insiders who reported open-market trades in the last 12 months at the companies Vlad Coric files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Vlad Coric is a corporate insider, tracked as Director of Royalty Pharma plc (RPRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Vlad Coric last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 5 filings going back to 2024.
Has Vlad Coric been buying or selling stock?
Recorded transactions: 5 open-market purchases ($8.00M) and 0 open-market sales across all tracked filings.
Vlad Coric is Director of Royalty Pharma plc (RPRX). 5 SEC Form 4 filings on record going back to 2024, most recently on 8 June 2026. Most recent open-market trade: bought $1000K of MANE on 6 February 2026. Lifetime open-market purchases: $8.00M.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by Vlad Coric.
InsiderAlpha's records for Vlad Coric go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $1.60M (5 buys totaling $8.00M). The largest single buy on record is $2.50M of BHVN in 2025. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
